Skip to Content

Bumetanide Injection

Last Updated: October 15, 2018
Status: Current

Products Affected - Description
    • Bumetanide injection, Pfizer, 0.25 mg/mL, 10 mL vial, 10 count, NDC 00409-1412-10
    • Bumetanide injection, Pfizer, 0.25 mg/mL, 4 mL vial, 10 count, NDC 00409-1412-04
Reason for the Shortage
    • Pfizer has bumetanide injection on shortage due to manufacturing delays.
    • Hikma did not provide a reason for the shortage.
Available Products
    • Bumetanide injection, Hikma, 0.25 mg/mL, 10 mL vial, 10 count, NDC 00641-6007-10
    • Bumetanide injection, Hikma, 0.25 mg/mL, 4 mL vial, 10 count, NDC 00641-6008-10

Estimated Resupply Dates

    • Pfizer has bumetanide 0.25 mg/mL 4 mL and 10 mL vials on back order and the company estimates a release date of 2nd quarter 2019 for the 4 mL vials and 2019 for the 10 mL vials.

Updated

Updated October 15, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Created May 4, 2017 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide